Shmuel Shoham

Research output

Research output per year 2000 2020 2021 2022 2023 2024

• 90 Article
• 30 Review article
• 9 Comment/debate
• 8 Chapter
• 9 More
  • 8 Letter
  • 1 Short survey

Research output per year

Research output per year

Search results

• 2024

  Convalescent plasma: An unexpected new therapeutic option for critically ill COVID-19 patients coming from the past

  Franchini, M., Casadevall, A., Cruciani, M., Joyner, M. J., Pirofski, L. A., Senefeld, J. W., Shoham, S., Sullivan, D. J. & Focosi, D., Jun 2024, In: Journal of Clinical Anesthesia. 94, 111411.

  Research output: Contribution to journal › Letter › peer-review

• Convalescent Plasma for Covid-19-Induced ARDS

  Casadevall, A., Shoham, S. & Pirofski, L. A., Jan 25 2024, In: The New England journal of medicine. 390, 4, p. 385-386 2 p.

  Research output: Contribution to journal › Letter › peer-review

  Open Access

• Safety and Efficacy of Convalescent Plasma Combined with Other Pharmaceutical Agents for Treatment of COVID-19 in Hospitalized Patients: A Systematic Review and Meta-Analysis

  Franchini, M., Focosi, D., Cruciani, M., Joyner, M. J., Pirofski, L. A., Senefeld, J. W., Shoham, S., Sullivan, D. & Casadevall, A., Mar 2024, In: Diseases. 12, 3, 41.

  Research output: Contribution to journal › Review article › peer-review

  Open Access
• 2023

  Absence of pathogenic viruses in COVID-19 convalescent plasma

  Kandathil, A. J., Benner, S. E., Bloch, E. M., Shrestha, R., Ajayi, O., Zhu, X., Caturegli, P. P., Shoham, S., Sullivan, D., Gebo, K., Quinn, T. C., Casadevall, A., Hanley, D., Pekosz, A., Redd, A. D., Balagopal, A. & Tobian, A. A. R., Jan 2023, In: Transfusion. 63, 1, p. 23-29 7 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Torque teno virus 100%
  • Viruses 44%
  • Anelloviridae 30%
  • Cytomegalovirus 24%
  • Human Herpesvirus 4 24%

• Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy

  Casadevall, A., Joyner, M. J., Pirofski, L. A., Senefeld, J. W., Shoham, S., Sullivan, D., Paneth, N. & Focosi, D., 2023, In: Expert review of respiratory medicine. 17, 5, p. 381-395 15 p.

  Research output: Contribution to journal › Review article › peer-review

  • Antibodies 100%
  • SARS Virus 59%
  • Immunocompromised Host 42%
  • expert opinions 34%
  • immunity 33%

• Coronavirus Disease 2019 Convalescent Plasma Reaches the Slope of Enlightenment in the Gartner Hype Cycle

  Shoham, S., Jun 15 2023, In: Clinical Infectious Diseases. 76, 12, p. 2087-2089 3 p.

  Research output: Contribution to journal › Comment/debate › peer-review

• Coronavirus Disease 2019 Convalescent Plasma Utilization in the United States: Data from the National Inpatient Sample

  Bloch, E. M., Goel, R., Zhu, X., Patel, E. U., Shoham, S., Sullivan, D. J., Gebo, K. A., Casadevall, A. & Tobian, A. A. R., Jul 15 2023, In: Clinical Infectious Diseases. 77, 2, p. 237-241 5 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Inpatients 63%
  • Geography 33%
  • Insurance 26%
  • Hospitalization 19%

• Discriminating endogenous vaccine-elicited anti-Spike antibody responses from exogenous anti-Spike monoclonal antibodies: The case of Evusheld

  Focosi, D., Maggi, F., Shoham, S. & Casadevall, A., Jan 2023, In: Journal of Medical Virology. 95, 1, e28277.

  Research output: Contribution to journal › Letter › peer-review

• Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study

  Zhu, X., Gebo, K. A., Abraham, A. G., Habtehyimer, F., Patel, E. U., Laeyendecker, O., Gniadek, T. J., Fernandez, R. E., Baker, O. R., Ram, M., Cachay, E. R., Currier, J. S., Fukuta, Y., Gerber, J. M., Heath, S. L., Meisenberg, B., Huaman, M. A., Levine, A. C., Shenoy, A., Anjan, S., & 28 othersBlair, J. E., Cruser, D., Forthal, D. N., Hammitt, L. L., Kassaye, S., Mosnaim, G. S., Patel, B., Paxton, J. H., Raval, J. S., Sutcliffe, C. G., Abinante, M., Broderick, P., Cluzet, V., Cordisco, M. E., Greenblatt, B., Petrini, J., Rausch, W., Shade, D., Lane, K., Gawad, A. L., Klein, S. L., Pekosz, A., Shoham, S., Casadevall, A., Bloch, E. M., Hanley, D., Sullivan, D. J. & Tobian, A. A. R., Sep 2023, In: The Lancet Microbe. 4, 9, p. e692-e703

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Chemokines 63%
  • Vaccination 54%
  • Cohort Studies 46%
  • Prospective Studies 43%

• Early antibody treatment, inflammation, and risk of post-COVID conditions

  CSSC-004 Consortium, Oct 2023, In: mBio. 14, 5

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Inflammation 100%
  • Antibodies 94%
  • SARS Virus 93%
  • Cytokines 52%
  • Interleukin-6 49%

• Guidance on the Use of Convalescent Plasma to Treat Immunocompromised Patients with Coronavirus Disease 2019

  Bloch, E. M., Focosi, D., Shoham, S., Senefeld, J., Tobian, A. A. R., Baden, L. R., Tiberghien, P., Sullivan, D. J., Cohn, C., Dioverti, V., Henderson, J. P., So-Osman, C., Juskewitch, J. E., Razonable, R. R., Franchini, M., Goel, R., Grossman, B. J., Casadevall, A., Joyner, M. J., Avery, R. K., & 2 othersPirofski, L. A. & Gebo, K. A., Jun 1 2023, In: Clinical Infectious Diseases. 76, 11, p. 2018-2024 7 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Coronavirus 100%
  • Immunocompromised Host 84%
  • Severe Acute Respiratory Syndrome 29%
  • Practice Guidelines 21%
  • Infectious Disease Medicine 19%

• Invasive fungal infections after respiratory viral infections in lung transplant recipients are associated with lung allograft failure and chronic lung allograft dysfunction within 1 year

  Permpalung, N., Liang, T., Gopinath, S., Bazemore, K., Mathew, J., Ostrander, D., Durand, C. M., Shoham, S., Zhang, S. X., Marr, K. A., Avery, R. K. & Shah, P. D., Jul 2023, In: Journal of Heart and Lung Transplantation. 42, 7, p. 953-963 11 p.

  Research output: Contribution to journal › Article › peer-review

  • Invasive Fungal Infections 100%
  • Respiratory Tract Infections 71%
  • Transplant Recipients 71%
  • Allografts 67%
  • Virus Diseases 56%

• Nirmatrelvir and COVID-19: development, pharmacokinetics, clinical efficacy, resistance, relapse, and pharmacoeconomics

  Focosi, D., McConnell, S., Shoham, S., Casadevall, A., Maggi, F. & Antonelli, G., Feb 2023, In: International Journal of Antimicrobial Agents. 61, 2, 106708.

  Research output: Contribution to journal › Review article › peer-review

  • Pharmaceutical Economics 100%
  • Ritonavir 96%
  • Pharmacokinetics 57%
  • Recurrence 43%
  • SARS Virus 22%

• Similar evolutionary trajectories in an environmental Cryptococcus neoformans isolate after human and murine infection

  Sephton-Clark, P., McConnell, S. A., Grossman, N., Baker, R. P., Dragotakes, Q., Fan, Y., Fu, M. S., Gerbig, G., Greengo, S., Hardwick, J. M., Kulkarni, M., Levitz, S. M., Nosanchuk, J. D., Shoham, S., Smith, D. F. Q., Stempinski, P., Timp, W., Wear, M. P., Cuomo, C. A. & Casadevall, A., Jan 10 2023, In: Proceedings of the National Academy of Sciences of the United States of America. 120, 2, e2217111120.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Cockatoos 100%
  • Cryptococcus neoformans 90%
  • Infections 34%
  • Pets 32%
  • Capsules 25%

• Transfusing Convalescent Plasma as Post-Exposure Prophylaxis Against Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection: A Double-Blinded, Phase 2 Randomized, Controlled Trial

  Shoham, S., Bloch, E. M., Casadevall, A., Hanley, D., Lau, B., Gebo, K., Cachay, E., Kassaye, S. G., Paxton, J. H., Gerber, J., Levine, A. C., Naeim, A., Currier, J., Patel, B., Allen, E. S., Anjan, S., Appel, L., Baksh, S., Blair, P. W., Bowen, A., & 36 othersBroderick, P., Caputo, C. A., Cluzet, V., Cordisco, M. E., Cruser, D., Ehrhardt, S., Forthal, D., Fukuta, Y., Gawad, A. L., Gniadek, T., Hammel, J., Huaman, M. A., Jabs, D. A., Jedlicka, A., Karlen, N., Klein, S., Laeyendecker, O., Lane, K., McBee, N., Meisenberg, B., Merlo, C., Mosnaim, G., Park, H. S., Pekosz, A., Petrini, J., Rausch, W., Shade, D. M., Shapiro, J. R., Robinson Singleton, J., Sutcliffe, C., Thomas, D. L., Yarava, A., Zand, M., Zenilman, J. M., Tobian, A. A. R. & Sullivan, D. J., Feb 1 2023, In: Clinical Infectious Diseases. 76, 3, p. E477-E486

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Post-Exposure Prophylaxis 100%
  • Severe Acute Respiratory Syndrome 88%
  • Coronavirus 60%
  • Randomized Controlled Trials 46%
  • Infections 13%

• Transfusion reactions associated with COVID-19 convalescent plasma in outpatient clinical trials

  Huaman, M. A., Raval, J. S., Paxton, J. H., Mosnaim, G. S., Patel, B., Anjan, S., Meisenberg, B. R., Levine, A. C., Marshall, C. E., Yarava, A., Shenoy, A. G., Heath, S. L., Currier, J. S., Fukuta, Y., Blair, J. E., Spivak, E. S., Petrini, J. R., Broderick, P. B., Rausch, W., Cordisco, M. E., & 38 othersHammel, J., Greenblatt, B., Cluzet, V. C., Cruser, D., Oei, K., Abinante, M., Hammitt, L. L., Sutcliffe, C. G., Forthal, D. N., Zand, M. S., Cachay, E. R., Kassaye, S. G., Ram, M., Wang, Y., Das, P., Lane, K., McBee, N. A., Gawad, A. L., Karlen, N., Ford, D. E., Laeyendecker, O., Pekosz, A., Klein, S. L., Ehrhardt, S., Lau, B., Baksh, S. N., Shade, D. M., Casadevall, A., Hanley, D. F., Ou, J., Gniadek, T. J., Ziman, A., Shoham, S., Gebo, K. A., Bloch, E. M., Tobian, A. A. R., Sullivan, D. J. & Gerber, J. M., Sep 2023, In: Transfusion. 63, 9, p. 1639-1648 10 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Transfusion Reaction 100%
  • Outpatients 56%
  • Clinical Trials 49%
  • Urticaria 17%
  • Hospitalization 16%

• Vaccines and therapeutics for immunocompromised patients with COVID-19

  Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force, May 2023, In: EClinicalMedicine. 59, 101965.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Immunocompromised Host 100%
  • Vaccines 70%
  • Vaccination 50%
  • SARS Virus 46%
  • Infectious Disease Transmission 37%
• 2022

  Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection

  Park, H. S., Shapiro, J. R., Sitaras, I., Woldemeskel, B. A., Garliss, C. C., Dziedzic, A., Sachithanandham, J., Jedlicka, A. E., Caputo, C. A., Rousseau, K. E., Thakar, M., Suwanmanee, S., Hauk, P., Aliyu, L., Majewska, N. I., Koley, S., Patel, B., Broderick, P., Mosnaim, G., Heath, S. L., & 18 othersSpivak, E. S., Shenoy, A., Bloch, E. M., Gniadek, T. J., Shoham, S., Casadevall, A., Hanley, D., Cox, A. L., Laeyendecker, O., Betenbaugh, M. J., Cramer, S. M., Mostafa, H. H., Pekosz, A., Blankson, J. N., Klein, S. L., Tobian, A. A. R., Sullivan, D. & Gebo, K. A., Mar 8 2022, In: JCI Insight. 7, 5, e155944.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Adaptive Immunity 69%
  • Neutralizing Antibodies 50%
  • Viruses 45%
  • Vaccination 40%

• Antibody attributes that predict the neutralization and effector function of polyclonal responses to SARS-CoV-2

  Natarajan, H., Xu, S., Crowley, A. R., Butler, S. E., Weiner, J. A., Bloch, E. M., Littlefield, K., Benner, S. E., Shrestha, R., Ajayi, O., Wieland-Alter, W., Sullivan, D., Shoham, S., Quinn, T. C., Casadevall, A., Pekosz, A., Redd, A. D., Tobian, A. A. R., Connor, R. I., Wright, P. F., & 1 othersAckerman, M. E., Dec 2022, In: BMC Immunology. 23, 1, 7.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Antibodies 37%
  • Antibody Formation 17%
  • Machine Learning 10%
  • Phagocytosis 9%

• Bloodstream Infections in Hematologic Malignancy Patients With Fever and Neutropenia: Are Empirical Antibiotic Therapies in the United States Still Effective?

  Zimmer, A. J., Stohs, E., Meza, J., Arnold, C., Baddley, J. W., Chandrasekar, P., El Boghdadly, Z., Gomez, C. A., Maziarz, E. K., Montoya, J. G., Pergam, S., Rolston, K. V., Satlin, M. J., Satyanarayana, G., Shoham, S., Strasfeld, L., Taplitz, R., Walsh, T. J., Young, J. A. H., Zhang, Y., & 1 othersFreifeld, A. G., Jul 1 2022, In: Open Forum Infectious Diseases. 9, 7, ofac240.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Hematologic Neoplasms 100%
  • Neutropenia 98%
  • Cefepime 79%
  • Tazobactam Drug Combination Piperacillin 77%
  • Fever 73%

• Convalescent plasma with a high level of virus-specific antibody effectively neutralizes SARS-CoV-2 variants of concern

  Li, M., Beck, E. J., Laeyendecker, O., Eby, Y., Tobian, A. A. R., Caturegli, P., Wouters, C., Chiklis, G. R., Block, W., McKie, R. O., Joyner, M. J., Wiltshire, T. D., Dietz, A. B., Gniadek, T. J., Shapiro, A. J., Yarava, A., Lane, K., Hanley, D. F., Bloch, E. M., Shoham, S., & 14 othersCachay, E. R., Meisenberg, B. R., Huaman, M. A., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Paxton, J. H., Anjan, S., Gerber, J. M., Gebo, K. A., Casadevall, A., Pekosz, A. & Sullivan, D. J., Jun 28 2022, In: Blood Advances. 6, 12, p. 3678-3683 6 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Viruses 51%
  • Antibodies 42%
  • Tissue Donors 30%

• Early Outpatient Treatment for Covid-19 with Convalescent Plasma

  Sullivan, D. J., Gebo, K. A., Shoham, S., Bloch, E. M., Lau, B., Shenoy, A. G., Mosnaim, G. S., Gniadek, T. J., Fukuta, Y., Patel, B., Heath, S. L., Levine, A. C., Meisenberg, B. R., Spivak, E. S., Anjan, S., Huaman, M. A., Blair, J. E., Currier, J. S., Paxton, J. H., Gerber, J. M., & 38 othersPetrini, J. R., Broderick, P. B., Rausch, W., Cordisco, M. E., Hammel, J., Greenblatt, B., Cluzet, V. C., Cruser, D., Oei, K., Abinante, M., Hammitt, L. L., Sutcliffe, C. G., Forthal, D. N., Zand, M. S., Cachay, E. R., Raval, J. S., Kassaye, S. G., Foster, E. C., Roth, M., Marshall, C. E., Yarava, A., Lane, K., McBee, N. A., Gawad, A. L., Karlen, N., Singh, A., Ford, D. E., Jabs, D. A., Appel, L. J., Shade, D. M., Ehrhardt, S., Baksh, S. N., Laeyendecker, O., Pekosz, A., Klein, S. L., Casadevall, A., Tobian, A. A. R. & Hanley, D. F., May 5 2022, In: New England Journal of Medicine. 386, 18, p. 1700-1711 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Outpatients 59%
  • Random Allocation 17%
  • Disease Progression 14%
  • Hospitalization 13%

• How do I implement an outpatient program for the administration of convalescent plasma for COVID-19?

  Bloch, E. M., Tobian, A. A. R., Shoham, S., Hanley, D. F., Gniadek, T. J., Cachay, E. R., Meisenberg, B. R., Kafka, K., Marshall, C., Heath, S. L., Shenoy, A., Paxton, J. H., Levine, A., Forthal, D., Fukuta, Y., Huaman, M. A., Ziman, A., Adamski, J., Gerber, J., Cruser, D., & 17 othersKassaye, S. G., Mosnaim, G. S., Patel, B., Metcalf, R. A., Anjan, S., Reisler, R. B., Yarava, A., Lane, K., McBee, N., Gawad, A., Raval, J. S., Zand, M., Abinante, M., Broderick, P. B., Casadevall, A., Sullivan, D. & Gebo, K. A., May 2022, In: Transfusion. 62, 5, p. 933-941 9 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Outpatients 100%
  • Pandemics 35%
  • Communicable Diseases 28%
  • Antibodies 18%
  • Workflow 18%

• Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel

  Bhimraj, A., Morgan, R. L., Shumaker, A. H., Baden, L., Chi-Chung Cheng, V., Edwards, K. M., Gandhi, R. T., Gallagher, J. C., Muller, W. J., O'Horo, J. C., Shoham, S., Wollins, D. S. & Falck-Ytter, Y., May 1 2022, In: Clinical Infectious Diseases. 74, 9, p. 1691-1695 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Coronavirus 100%
  • Communicable Diseases 68%
  • Pandemics 63%
  • Guidelines 51%
  • Emerging Communicable Diseases 27%

• Limitations on PassItOn Design and Execution Should Temper Negative Conclusions

  Shoham, S. & Focosi, D., Nov 2022, In: CHEST. 162, 5, p. e282-e283

  Research output: Contribution to journal › Letter › peer-review

• Pharmacokinetics of high-titer anti–SARS-CoV-2 human convalescent plasma in high-risk children

  Gordon, O., Brosnan, M. K., Yoon, S., Jung, D., Littlefield, K., Ganesan, A., Caputo, C. A., Li, M., Morgenlander, W. R., Henson, S. N., Ordonez, A. A., De Jesus, P., Tucker, E. W., Akindele, N. P., Ma, Z., Wilson, J., Ruiz-Bedoya, C. A., Elizabeth, M., Bloch, E. M., Shoham, S., & 10 othersSullivan, D., Tobian, A. A. R., Cooke, K. R., Larman, B., Gobburu, J. V. S., Casadevall, A., Pekosz, A., Lederman, H. M., Klein, S. L. & Jain, S. K., Jan 25 2022, In: JCI Insight. 7, 2, e151518.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Pharmacokinetics 100%
  • Child 57%
  • SARS Virus 48%
  • Tissue Donors 38%
  • Antibodies 36%

• The Potential Role of Passive Antibody-Based Therapies as Treatments for Monkeypox

  Bloch, E. M., Sullivan, D. J., Shoham, S., Tobian, A. A. R., Casadevall, A. & Gebo, K. A., Dec 2022, In: mBio. 13, 6

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Monkeypox 100%
  • Antibodies 32%
  • Disease Outbreaks 31%
  • Monkeypox virus 29%
  • Antiviral Agents 20%

• Therapeutic Emergency Use Authorizations (EUAs) During Pandemics: Double-edged Swords

  Bhimraj, A., Morgan, R. L., Shumaker, A. H., Lavergne, V., Baden, L., Cheng, V. C. C., Edwards, K. M., Gandhi, R. T., Gallagher, J. C., Muller, W. J., O'Horo, J. C., Shoham, S., Wollins, D. S. & Falck-Ytter, Y., May 1 2022, In: Clinical Infectious Diseases. 74, 9, p. 1686-1690 5 p.

  Research output: Contribution to journal › Article › peer-review

  • Pandemics 100%
  • Therapeutic Uses 77%
  • Emergencies 72%
  • Coronavirus 23%
  • United States Food and Drug Administration 18%

• The silent and dangerous inequity around access to COVID-19 testing: A call to action

  Batista, C., Hotez, P., Amor, Y. B., Kim, J. H., Kaslow, D., Lall, B., Ergonul, O., Figueroa, J. P., Gursel, M., Hassanain, M., Kang, G., Larson, H., Naniche, D., Sheahan, T., Wilder-Smith, A., Shoham, S., Sow, S. O., Yadav, P., Strub-Wourgaft, N., Loveday, S. J., & 2 othersHannay, E. & Bottazzi, M. E., Jan 2022, In: EClinicalMedicine. 43, 101230.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Treatment recommendations for non-HIV associated cryptococcal meningoencephalitis including management of post-infectious inflammatory response syndrome

  Ssebambulidde, K., Anjum, S. H., Hargarten, J. C., Chittiboina, P., Shoham, S., Seyedmousavi, S., Marr, K. A., Hammoud, D. A., Billioux, B. J. & Williamson, P. R., Dec 1 2022, In: Frontiers in Neurology. 13, 994396.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Meningoencephalitis 100%
  • Transplantation Conditioning 42%
  • HIV 36%
  • Immune Reconstitution 34%
  • Morbidity 30%

• WHO covid-19 drugs guideline: Reconsider using convalescent plasma

  Paneth, N., Casadevall, A., Pirofski, L. A., Henderson, J. P., Grossman, B. J., Shoham, S. & Joyner, M. J., Feb 8 2022, In: The BMJ. 376, o295.

  Research output: Contribution to journal › Letter › peer-review
• 2021

  ABO blood group and SARS-CoV-2 antibody response in a convalescent donor population

  Bloch, E. M., Patel, E. U., Marshall, C., Littlefield, K., Goel, R., Grossman, B. J., Winters, J. L., Shrestha, R., Burgess, I., Laeyendecker, O., Shoham, S., Sullivan, D., Gehrie, E. A., Redd, A. D., Quinn, T. C., Casadevall, A., Pekosz, A. & Tobian, A. A. R., Aug 2021, In: Vox sanguinis. 116, 7, p. 766-773 8 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Blood Group Antigens 73%
  • Antibody Formation 60%
  • Neutralizing Antibodies 39%
  • Population 26%
  3 Scopus citations

• Achieving global equity for COVID-19 vaccines: Stronger international partnerships and greater advocacy and solidarity are needed

  Figueroa, J. P., Hotez, P. J., Batista, C., Amor, Y. B., Ergonul, O., Gilbert, S., Gursel, M., Hassanain, M., Kang, G., Kaslow, D. C., Kim, J. H., Lall, B., Larson, H., Naniche, D., Sheahan, T., Shoham, S., Wilder-Smith, A., Sow, S. O., Strub-Wourgaft, N., Yadav, P., & 1 othersBottazzi, M. E., Sep 2021, In: PLoS medicine. 18, 9, e1003772.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

• Antibody responses to endemic coronaviruses modulate COVID-19 convalescent plasma functionality

  Morgenlander, W., Henson, S., Monaco, D. R., Chen, A., Littlefield, K., Bloch, E. M., Fujimura, E., Ruczinski, I., Crowley, A. R., Natarajan, H., Butler, S. E., Weiner, J. A., Li, M. Z., Bonny, T. S., Benner, S. E., Balagopal, A., Sullivan, D., Shoham, S., Quinn, T. C., Eshleman, S., & 9 othersCasadevall, A., Redd, A. D., Laeyendecker, O., Ackerman, M. E., Pekosz, A., Elledge, S. J., Robinson, M., Tobian, A. A. R. & Larman, H. B., Apr 1 2021, In: Journal of Clinical Investigation. 131, 7

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Coronavirus 100%
  • Antibody Formation 71%
  • Peptides 25%
  • SARS Virus 23%
  • Antibodies 22%
  4 Scopus citations

• Beyond the jab: A need for global coordination of pharmacovigilance for COVID-19 vaccine deployment

  Naniche, D., Hotez, P., Bottazzi, M. E., Ergonul, O., Figueroa, J. P., Gilbert, S., Gursel, M., Hassanain, M., Kang, G., Kaslow, D., Kim, J. H., Lall, B., Larson, H., Sheahan, T., Shoham, S., Wilder-Smith, A., Sow, S. O., Strub-Wourgaft, N., Yadav, P. & Batista, C., Jun 2021, In: EClinicalMedicine. 36, 100925.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access

• Comparative performance of five commercially available serologic assays to detect antibodies to SARS-CoV-2 and identify individuals with high neutralizing titers

  Patel, E. U., Bloch, E. M., Clarke, W., Hsieh, Y. H., Boon, D., Eby, Y., Fernandez, R. E., Baker, O. R., Keruly, M., Kirby, C. S., Klock, E., Littlefield, K., Miller, J., Schmidt, H. A., Sullivan, P., Piwowar-Manning, E., Shrestha, R., Redd, A. D., Rothman, R. E., Sullivan, D., & 6 othersShoham, S., Casadevall, A., Quinn, T. C., Pekosz, A., Tobian, A. A. R. & Laeyendecker, O., Feb 2021, In: Journal of clinical microbiology. 59, 2, e02257-20.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • Immunoenzyme Techniques 79%
  • Antibodies 42%
  • Tissue Donors 30%
  15 Scopus citations

• Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers

  Heaney, C. D., Pisanic, N., Randad, P. R., Kruczynski, K., Howard, T., Zhu, X., Littlefield, K., Patel, E. U., Shrestha, R., Laeyendecker, O. B., Shoham, S., Sullivan, D., Gebo, K., Hanley, D., Redd, A., Quinn, T. C., Casadevall, A., Zenilman, J. M., Pekosz, A., Bloch, E. M., & 1 othersTobian, A. A. R., Dec 2021, In: Journal of Clinical Virology. 145, 104997.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • SARS Virus 100%
  • Neutralizing Antibodies 67%
  • Immunoenzyme Techniques 55%
  • Immunoglobulin G 51%
  • Nucleocapsid 17%

• Convalescent Plasma Therapy for COVID-19: A Graphical Mosaic of the Worldwide Evidence

  Klassen, S. A., Senefeld, J. W., Senese, K. A., Johnson, P. W., Wiggins, C. C., Baker, S. E., van Helmond, N., Bruno, K. A., Pirofski, L. A., Shoham, S., Grossman, B. J., Henderson, J. P., Wright, R. S., Fairweather, D. L., Paneth, N. S., Carter, R. E., Casadevall, A. & Joyner, M. J., Jun 7 2021, In: Frontiers in Medicine. 8, 684151.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Coronavirus 100%
  • Survival 35%
  • Randomized Controlled Trials 16%
  • Therapeutics 13%
  • Global Health 7%

• Correcting COVID-19 vaccine misinformation: Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members*

  Hotez, P., Batista, C., Ergonul, O., Figueroa, J. P., Gilbert, S., Gursel, M., Hassanain, M., Kang, G., Kim, J. H., Lall, B., Larson, H., Naniche, D., Sheahan, T., Shoham, S., Wilder-Smith, A., Strub-Wourgaft, N., Yadav, P. & Bottazzi, M. E., Mar 2021, In: EClinicalMedicine. 33, 100780.

  Research output: Contribution to journal › Comment/debate › peer-review

  Open Access
  4 Scopus citations

• Cytokine and Chemokine Levels in Coronavirus Disease 2019 Convalescent Plasma

  Bonny, T. S., Patel, E. U., Zhu, X., Bloch, E. M., Grabowski, M. K., Abraham, A. G., Littlefield, K., Shrestha, R., Benner, S. E., Laeyendecker, O., Shoham, S., Sullivan, D., Quinn, T. C., Casadevall, A., Pekosz, A., Redd, A. D. & Tobian, A. A. R., Feb 1 2021, In: Open Forum Infectious Diseases. 8, 2, ofaa574.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Coronavirus 100%
  • Chemokines 74%
  • Severe Acute Respiratory Syndrome 51%
  • Cytokines 49%
  • Tissue Donors 31%
  3 Scopus citations

• EORTC/MSGERC Definitions of Invasive Fungal Diseases: Summary of Activities of the Intensive Care Unit Working Group

  Bassetti, M., Azoulay, E., Kullberg, B. J., Ruhnke, M., Shoham, S., Vazquez, J., Giacobbe, D. R. & Calandra, T., Mar 15 2021, In: Clinical Infectious Diseases. 72, p. S121-S127

  Research output: Contribution to journal › Article › peer-review

  • Mycoses 100%
  • Intensive Care Units 82%
  • Immunocompromised Host 41%
  • Invasive Candidiasis 28%
  • Host Specificity 24%
  1 Scopus citations

• Global public health security and justice for vaccines and therapeutics in the COVID-19 pandemic

  Hotez, P. J., Batista, C., Amor, Y. B., Ergonul, O., Figueroa, J. P., Gilbert, S., Gursel, M., Hassanain, M., Kang, G., Kaslow, D. C., Kim, J. H., Lall, B., Larson, H., Naniche, D., Sheahan, T., Shoham, S., Wilder-Smith, A., Sow, S. O., Strub-Wourgaft, N., Yadav, P., & 1 othersBottazzi, M. E., Sep 2021, In: EClinicalMedicine. 39, 101053.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Social Justice 100%
  • Pandemics 85%
  • Global Health 78%
  • Vaccines 59%
  • Public Health 56%

• Markers of polyfunctional sars-cov-2 antibodies in convalescent plasma

  Natarajan, H., Crowley, A. R., Butler, S. E., Xu, S., Weiner, J. A., Bloch, E. M., Littlefield, K., Wieland-Alter, W., Connor, R. I., Wright, P. F., Benner, S. E., Bonny, T. S., Laeyendecker, O., Sullivan, D., Shoham, S., Quinn, T. C., Larman, H. B., Casadevall, A., Pekosz, A., Redd, A. D., & 2 othersTobian, A. A. R. & Ackerman, M. E., 2021, In: mBio. 12, 2, e00765-21.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Antibodies 100%
  • Coronavirus 94%
  • Severe Acute Respiratory Syndrome 58%
  • Antiviral Agents 51%
  • Antibody Diversity 24%
  1 Scopus citations

• Operation Warp Speed: implications for global vaccine security

  Lancet Commission on COVID-19 Vaccines and Therapeutics Task Force Members, Jul 2021, In: The Lancet Global Health. 9, 7, p. e1017-e1021

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Vaccines 100%
  • Diplomacy 40%
  • Social Justice 27%
  • Licensure 24%
  • Microbiology 23%
  1 Scopus citations

• Outcomes of SOT Recipients with COVID-19 in Different Eras of COVID-19 Therapeutics

  Sait, A. S., Chiang, T. P. Y., Marr, K. A., Massie, A. B., Cochran, W., Shah, P., Brennan, D. C., Thomas, A. G., Mehta Steinke, S., Permpalung, N., Shoham, S., Merlo, C., Jain, T., Boyarsky, B., Charnaya, O., Gurakar, A., Sharma, K., Durand, C. M., Werbel, W. A., Huang, C. Y., & 9 othersOstrander, D., Desai, N., Kim, M. Y., Alasfar, S., Bloch, E. M., Tobian, A. A. R., Garonzik-Wang, J., Segev, D. L. & Avery, R. K., Dec 23 2021, In: Transplantation Direct. 8, 1, p. E1268

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • GS-5734 100%
  • Coronavirus 73%
  • Dexamethasone 43%
  • Transplants 29%
  • Inpatients 28%

• Outcomes of transplant recipients treated with cidofovir for resistant or refractory cytomegalovirus infection

  Mehta Steinke, S. A., Alfares, M., Valsamakis, A., Shoham, S., Arav-Boger, R., Lees, L., Ostrander, D., Forman, M. S., Shedeck, A., Ambinder, R. F., Jones, R. J. & Avery, R. K., Jun 2021, In: Transplant Infectious Disease. 23, 3, e13521.

  Research output: Contribution to journal › Article › peer-review

  • Cidofovir 100%
  • Cytomegalovirus Infections 75%
  • Transplant Recipients 63%
  • Cytomegalovirus 53%
  • Transplants 42%

• Pneumocystis jiroveci in Transplant: Recognizing Risk, Understanding Prevention, and Implementing Treatment

  Shoham, S. & Prono, M. V. D., Jan 1 2021, Emerging Transplant Infections: Clinical Challenges and Implications. Springer International Publishing, p. 1183-1206 24 p.

  Research output: Chapter in Book/Report/Conference proceeding › Chapter

  • Pneumocystis carinii 100%
  • Transplants 47%
  • Graft vs Host Disease 26%
  • HIV 26%
  • polyglucosan 19%

• Quantifying infection risks in incompatible living donor kidney transplant recipients

  Avery, R. K., Motter, J. D., Jackson, K. R., Montgomery, R. A., Massie, A. B., Kraus, E. S., Marr, K. A., Lonze, B. E., Alachkar, N., Holechek, M. J., Ostrander, D., Desai, N., Waldram, M. M., Shoham, S., Steinke, S. M., Subramanian, A., Hiller, J. M., Langlee, J., Young, S., Segev, D. L., & 1 othersGaronzik Wang, J. M., Apr 2021, In: American Journal of Transplantation. 21, 4, p. 1564-1575 12 p.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Living Donors 100%
  • Transplant Recipients 82%
  • Kidney Transplantation 48%
  • Kidney 47%
  • Infections 42%
  1 Scopus citations

• SARS-CoV-2-specific CD8⁺ T cell responses in convalescent COVID-19 individuals

  Kared, H., Redd, A. D., Bloch, E. M., Bonny, T. S., Sumatoh, H., Kairi, F., Carbajo, D., Abel, B., Newell, E. W., Bettinotti, M. P., Benner, S. E., Patel, E. U., Littlefield, K., Laeyendecker, O., Shoham, S., Sullivan, D., Casadevall, A., Pekosz, A., Nardin, A., Fehlings, M., & 2 othersTobian, A. A. R. & Quinn, T. C., Mar 1 2021, In: Journal of Clinical Investigation. 131, 5, e145476.

  Research output: Contribution to journal › Article › peer-review

  Open Access

  • Severe Acute Respiratory Syndrome 100%
  • Coronavirus 97%
  • T-Lymphocytes 47%
  • Epitopes 16%
  • T-Lymphocyte Epitopes 11%
  7 Scopus citations

• The Effect of Convalescent Plasma Therapy on Mortality Among Patients With COVID-19: Systematic Review and Meta-analysis

  Klassen, S. A., Senefeld, J. W., Johnson, P. W., Carter, R. E., Wiggins, C. C., Shoham, S., Grossman, B. J., Henderson, J. P., Musser, J., Salazar, E., Hartman, W. R., Bouvier, N. M., Liu, S. T. H., Pirofski, L. A., Baker, S. E., van Helmond, N., Wright, R. S., Fairweather, D. L., Bruno, K. A., Wang, Z., & 3 othersPaneth, N. S., Casadevall, A. & Joyner, M. J., May 2021, In: Mayo Clinic proceedings. 96, 5, p. 1262-1275 14 p.

  Research output: Contribution to journal › Review article › peer-review

  Open Access

  • Meta-Analysis 100%
  • Systematic Reviews 98%
  • Mortality 67%
  • Randomized Controlled Trials 36%
  • MEDLINE 23%
  2 Scopus citations